Proposed Cold MD settlement
This article was originally published in The Tan Sheet
Executive Summary
Iomedix Cold International agrees to make refunds to consumers who bought the Cold MD dietary supplement between March 26, 2004, and May 29, 2009. Consumers could receive $5 to $10 per bottle that they purchased as part of a proposed class action settlement. The settlement would resolve allegations the Mississauga, Ontario-based firm made false claims about Cold MD, according to a July 7 press release. The National Advertising Division previously ruled Iovate failed to substantiate efficacy claims (1"The Tan Sheet" April 30, 2007)
You may also be interested in...
Trial Of Cold MD Ingredients Fails To Substantiate Efficacy Claims – NAD
Iovate Health Sciences "strongly disagrees" with the National Advertising Division's recommendation to discontinue some product claims for its Cold MD dietary supplement, but said it will comply with the Council of Better Business Bureaus unit's April 20 decision
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.